source
- Scancell plans Neuphoria merger; AstraZeneca wins EU nod for cancer drugScancell to merge into Neuphoria: Scancell plans to take over Neuphoria Therapeutics' Nasdaq listing {$NEUP} and change the ticker to SCLT. The company eyes up to $89 million in equity and ...Endpoints · 9d ago↗ source
- From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotechWhether it's looming tariff threats or the rise of China, you need a truly global view to navigate today's biopharma industry.Fierce Biotech · 9d ago↗ source
- Biogen counts on drugs from Apellis deal to patch Leqembi's slow salesIt’s no secret that sales of Leqembi have been disappointing. First approved in 2023, the Alzheimer’s drug from Eisai and Biogen launched shortly after Chris Viehbacher took the reins as Biogen CEO…